Published in Gene Therapy Weekly, August 2nd, 2007
"These experimental conditions are shown to enhance specific protein-protein interactions while decreasing nonspecific aggregation. In addition, Xe-129 NMR chemical shifts become selective reporters of one particular oligomer in the presence of arginine and glutamic acid, indicating that a specific Xe binding site is...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.